30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Lannett Company Inc (LCI)

Track

Stock chart
Ticker: LCI Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Chapman John C
1 purchase — total 10,200 USD
Buy 17 Nov 2022
Value US$2,389,697.23 | Price 247.00 | Shares 81,842
Buy 10 Nov 2022
Value US$3,770,807.74 | Price 314.86 | Shares 86,608
Planned buy 10 Nov 2022
Value US$7,200.00 | Price 0.48 | Shares 15,000
Buy 14 Sep 2022
Value US$15,267.91 | Price 0.49 | Shares 31,159
Buy 16 May 2022
Value US$27,000.00 | Price 0.54 | Shares 50,000
Buy 17 Mar 2022
Value US$16,200.00 | Price 0.81 | Shares 20,000
Buy 15 Feb 2022
Value US$9,720.00 | Price 0.81 | Shares 12,000
Buy 11 Feb 2022
Value US$10,000.00 | Price 0.80 | Shares 12,500
Buy 10 Feb 2022
Value US$4,500.00 | Price 0.90 | Shares 5,000
Planned buy 10 Feb 2022
Value US$46,500.00 | Price 0.93 | Shares 50,000
Buy 9 Feb 2022
Value US$9,200.00 | Price 0.92 | Shares 10,000
Buy 8 Feb 2022
Value US$44,000.00 | Price 0.88 | Shares 50,000
Buy 14 Dec 2021
Value US$8,869.00 | Price 1.81 | Shares 4,900
Planned buy 13 Dec 2021
Value US$39,800.00 | Price 1.99 | Shares 20,000
Buy 2 Dec 2021
Value US$6,720.00 | Price 1.68 | Shares 4,000
Buy 29 Nov 2021
Value US$85,500.00 | Price 1.71 | Shares 50,000
Buy 17 Nov 2021
Value US$19,300.00 | Price 1.93 | Shares 10,000
Buy 16 Nov 2021
Value US$14,420.00 | Price 2.06 | Shares 7,000
Sale 9 Sep 2021
Value US$80,581.20 | Price 3.18 | Shares 25,340
Buy 28 May 2021
Value US$43,700.00 | Price 4.37 | Shares 10,000
Buy 11 May 2021
Value US$83,600.00 | Price 4.18 | Shares 20,000
Sale 8 Feb 2021
Value US$203,345.60 | Price 6.08 | Shares 33,445
Planned buy 10 Nov 2020
Value US$18,120.00 | Price 6.04 | Shares 3,000
Sale 3 Sep 2020
Value US$75,278.00 | Price 5.32 | Shares 14,150
Sale 3 Sep 2020
Value US$5,270.00 | Price 5.27 | Shares 1,000
Planned buy 1 Sep 2020
Value US$15,300.00 | Price 5.10 | Shares 3,000
Sale 19 May 2020
Value US$216,600.00 | Price 7.22 | Shares 30,000
Sale 19 May 2020
Value US$274,311.40 | Price 7.37 | Shares 37,220
Planned buy 12 May 2020
Value US$22,710.00 | Price 7.57 | Shares 3,000
Planned buy 11 Nov 2019
Value US$17,980.00 | Price 8.99 | Shares 2,000
Sale 9 Sep 2019
Value US$203,085.30 | Price 12.54 | Shares 16,195
Sale 6 Sep 2019
Value US$119,294.60 | Price 10.30 | Shares 11,582
Buy 3 Sep 2019
Value US$245,500.00 | Price 9.82 | Shares 25,000
Planned buy 29 Aug 2019
Value US$16,900.00 | Price 8.45 | Shares 2,000
Buy 15 May 2019
Value US$29,000.00 | Price 5.80 | Shares 5,000
Planned buy 10 May 2019
Value US$20,550.00 | Price 6.85 | Shares 3,000
Buy 9 May 2019
Value US$68,500.00 | Price 6.85 | Shares 10,000
Buy 8 May 2019
Value US$183,000.00 | Price 7.32 | Shares 25,000
Buy 12 Feb 2019
Value US$223,250.00 | Price 8.93 | Shares 25,000
Planned buy 11 Feb 2019
Value US$33,920.00 | Price 8.48 | Shares 4,000
Buy 14 Dec 2018
Value US$49,300.00 | Price 4.93 | Shares 10,000
Buy 13 Dec 2018
Value US$127,500.00 | Price 5.10 | Shares 25,000
Buy 13 Dec 2018
Value US$50,700.00 | Price 5.07 | Shares 10,000
Buy 12 Dec 2018
Value US$53,200.00 | Price 5.32 | Shares 10,000
Planned buy 9 Nov 2018
Value US$10,700.00 | Price 5.35 | Shares 2,000
Buy 31 Aug 2018
Value US$133,500.00 | Price 5.34 | Shares 25,000
Planned buy 29 Aug 2018
Value US$11,020.00 | Price 5.51 | Shares 2,000
Sale 14 Jun 2018
Value US$192,622.17 | Price 16.51 | Shares 11,667
Buy 11 May 2018
Value US$378,250.00 | Price 15.13 | Shares 25,000
Planned buy 10 May 2018
Value US$29,460.00 | Price 14.73 | Shares 2,000
Planned sale 9 Jan 2018
Value US$250,100.00 | Price 25.01 | Shares 10,000
Sale 13 Dec 2017
Value US$5,520.00 | Price 30.00 | Shares 184
Planned sale 5 Dec 2017
Value US$261,915.80 | Price 30.05 | Shares 8,716
Planned sale 4 Dec 2017
Value US$33,011.00 | Price 30.01 | Shares 1,100
Planned sale 1 Dec 2017
Value US$268,800.00 | Price 26.88 | Shares 10,000
Sale 27 Nov 2017
Value US$15,866.10 | Price 27.45 | Shares 578
Sale 24 Nov 2017
Value US$1,337,500.00 | Price 26.75 | Shares 50,000
Sale 22 Nov 2017
Value US$1,071,000.00 | Price 25.50 | Shares 42,000
Sale 8 Nov 2017
Value US$187,034.40 | Price 25.20 | Shares 7,422
Planned sale 8 Nov 2017
Value US$245,294.00 | Price 25.03 | Shares 9,800
Planned sale 7 Nov 2017
Value US$5,000.00 | Price 25.00 | Shares 200
Buy 6 Feb 2017
Value US$200,000.00 | Price 20.00 | Shares 10,000
Planned sale 13 Dec 2016
Value US$5,000.00 | Price 25.00 | Shares 200
Planned sale 9 Dec 2016
Value US$151,800.00 | Price 25.30 | Shares 6,000
Planned sale 2 Dec 2016
Value US$95,000.00 | Price 25.00 | Shares 3,800
Sale 15 Sep 2016
Value US$139,988.20 | Price 32.30 | Shares 4,334
Planned sale 1 Sep 2016
Value US$50,118.98 | Price 33.91 | Shares 1,478
Sale 31 Aug 2016
Value US$15,130.20 | Price 33.40 | Shares 453
Sale 31 Aug 2016
Value US$144,765.53 | Price 33.41 | Shares 4,333
Sale 31 Aug 2016
Value US$66,820.00 | Price 33.41 | Shares 2,000
Planned sale 23 Jun 2016
Value US$524,844.54 | Price 25.02 | Shares 20,977
Planned sale 22 Jun 2016
Value US$406,039.68 | Price 25.12 | Shares 16,164
Planned sale 20 Jun 2016
Value US$1,596,618.60 | Price 25.40 | Shares 62,859
Sale 1 Mar 2016
Value US$1,759,566.27 | Price 25.41 | Shares 69,247
Buy 5 Feb 2016
Value US$24,840.00 | Price 24.84 | Shares 1,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-11-18 2022-11-17 B Purchase
0.6
Chapman John C
Non-Executive Director
81,842 -38.0%
247.00
US$2,389,697 		81,842 -38.0% 247.00 US$2,389,697
2022-11-14 2022-11-10 B Purchase
2.5
LEPORE PATRICK G
Non-Executive Director
86,608 -12.4%
314.86
US$3,770,808 		86,608 -12.4% 314.86 US$3,770,808
2022-11-14 2022-11-10 PP Planned purchase
Crew Timothy C

Chief Executive Officer

Officer
7,116 -12.9%
489.03
US$2,932,888 		7,116 -12.9% 489.03 US$2,932,888
2022-09-15 2022-09-14 B Purchase
2.7
Rewolinski Melissa
Non-Executive Director
31,159 +50.2%
0.49
US$15,268 		31,159 +50.2% 0.49 US$15,268
2022-05-17 2022-05-16 B Purchase
2.5
LEPORE PATRICK G
Non-Executive Director
50,000 +11.4%
0.54
US$27,000 		50,000 +11.4% 0.54 US$27,000
2022-03-21 2022-03-17 B Purchase
3.8
FARBER JEFFREY
Non-Executive Director Large shareholder
20,000 +0.9%
0.81
US$16,200 		20,000 +0.9% 0.81 US$16,200
2022-02-15 2022-02-15 B Purchase
1.2
Israel Samuel H

Chief Legal Officer

Officer
12,000 +7.3%
0.81
US$9,720 		12,000 +7.3% 0.81 US$9,720
2022-02-15 2022-02-11 B Purchase
0.6
Chapman John C
Non-Executive Director
12,500 +8.8%
0.80
US$10,000 		12,500 +8.8% 0.80 US$10,000
2022-02-11 2022-02-10 B Purchase
1.1
Abt John

Chief Quality and Operations

Officer
5,000 +4.0%
0.90
US$4,500 		5,000 +4.0% 0.90 US$4,500
2022-02-11 2022-02-10 PP Planned purchase
Crew Timothy C

Chief Executive Officer

Officer
50,000 +8.6%
0.93
US$46,500 		50,000 +8.6% 0.93 US$46,500
2022-02-10 2022-02-09 B Purchase
3.8
FARBER JEFFREY
Non-Executive Director Large shareholder
10,000 +0.5%
0.92
US$9,200 		10,000 +0.5% 0.92 US$9,200
2022-02-10 2022-02-08 B Purchase
2.5
LEPORE PATRICK G
Non-Executive Director
50,000 +12.9%
0.88
US$44,000 		50,000 +12.9% 0.88 US$44,000
2021-12-14 2021-12-14 B Purchase
1.0
KOZLOWSKI JOHN

VP of Finance & CFO

Officer
4,900 +3.2%
1.81
US$8,869 		4,900 +3.2% 1.81 US$8,869
2021-12-14 2021-12-13 PP Planned purchase
Crew Timothy C

Chief Executive Officer

Officer
20,000 +3.5%
1.99
US$39,800 		20,000 +3.5% 1.99 US$39,800
2021-12-02 2021-12-02 B Purchase
1.0
KOZLOWSKI JOHN

VP of Finance & CFO

Officer
4,000 +2.7%
1.68
US$6,720 		4,000 +2.7% 1.68 US$6,720
2021-11-30 2021-11-29 B Purchase
2.5
LEPORE PATRICK G
Non-Executive Director
50,000 +14.8%
1.71
US$85,500 		50,000 +14.8% 1.71 US$85,500
2021-12-01 2021-11-17 B Purchase
3.8
FARBER JEFFREY
Non-Executive Director Large shareholder
10,000 +0.5%
1.93
US$19,300 		10,000 +0.5% 1.93 US$19,300
2021-11-16 2021-11-16 B Purchase
1.0
KOZLOWSKI JOHN

VP of Finance & CFO

Officer
7,000 +4.9%
2.06
US$14,420 		7,000 +4.9% 2.06 US$14,420
2021-09-13 2021-09-09 S Sale
2.7
Rewolinski Melissa
Non-Executive Director
25,340 -29.0%
3.18
US$80,581 		25,340 -29.0% 3.18 US$80,581
2021-06-01 2021-05-28 B Purchase
3.8
FARBER JEFFREY
Non-Executive Director Large shareholder
10,000 +0.6%
4.37
US$43,700 		10,000 +0.6% 4.37 US$43,700
2021-05-12 2021-05-11 B Purchase
2.5
LEPORE PATRICK G
Non-Executive Director
20,000 +8.3%
4.18
US$83,600 		20,000 +8.3% 4.18 US$83,600
2021-02-10 2021-02-08 S Sale
3.0
Drabik David A
Non-Executive Director
33,445 -39.4%
6.08
US$203,346 		33,445 -39.4% 6.08 US$203,346
2020-11-12 2020-11-10 PP Planned purchase
Crew Timothy C

Chief Executive Officer

Officer
3,000 +0.8%
6.04
US$18,120 		3,000 +0.8% 6.04 US$18,120
2021-06-10 2020-09-03 S Sale
2.7
Rewolinski Melissa
Non-Executive Director
14,150 -31.6%
5.32
US$75,278 		14,150 -31.6% 5.32 US$75,278
2020-09-04 2020-09-03 S Sale
1.1
Abt John

Chief Quality and Operations

Officer
1,000 -1.1%
5.27
US$5,270 		1,000 -1.1% 5.27 US$5,270
2020-09-02 2020-09-01 PP Planned purchase
Crew Timothy C

Chief Executive Officer

Officer
3,000 +0.8%
5.10
US$15,300 		3,000 +0.8% 5.10 US$15,300
2020-05-21 2020-05-19 S Sale
2.4
Taveira Paul
Non-Executive Director
30,000 -36.8%
7.22
US$216,600 		30,000 -36.8% 7.22 US$216,600
2020-05-21 2020-05-19 S Sale
3.0
Drabik David A
Non-Executive Director
37,220 -44.7%
7.37
US$274,311 		37,220 -44.7% 7.37 US$274,311
2020-05-13 2020-05-12 PP Planned purchase
Crew Timothy C

Chief Executive Officer

Officer
3,000 +1.6%
7.57
US$22,710 		3,000 +1.6% 7.57 US$22,710
2019-11-12 2019-11-11 PP Planned purchase Crew Timothy C

Chief Executive Officer

Officer
2,000 +1.1%
8.99
US$17,980 		2,000 +1.1% 8.99 US$17,980
2019-09-11 2019-09-09 S Sale
3.2
PAONESSA ALBERT III
16,195 -26.1%
12.54
US$203,085 		16,195 -26.1% 12.54 US$203,085
2019-09-06 2019-09-06 S Sale
3.2
PAONESSA ALBERT III
11,582 -15.7%
10.30
US$119,295 		11,582 -15.7% 10.30 US$119,295
2019-09-05 2019-09-03 B Purchase
2.5
LEPORE PATRICK G
25,000 +14.2%
9.82
US$245,500 		25,000 +14.2% 9.82 US$245,500
2019-09-03 2019-08-29 PP Planned purchase
Crew Timothy C

Chief Executive Officer
2,000 +1.1%
8.45
US$16,900 		2,000 +1.1% 8.45 US$16,900
2019-05-15 2019-05-15 B Purchase
3.8
FARBER JEFFREY
Non-Executive Director
5,000 +0.2%
5.80
US$29,000 		5,000 +0.2% 5.80 US$29,000
2019-05-10 2019-05-10 PP Planned purchase
Crew Timothy C

Chief Executive Officer
3,000 +6.3%
6.85
US$20,550 		3,000 +6.3% 6.85 US$20,550
2019-05-09 2019-05-09 B Purchase
3.8
FARBER JEFFREY
Non-Executive Director
10,000 +0.5%
6.85
US$68,500 		10,000 +0.5% 6.85 US$68,500
2019-05-09 2019-05-08 B Purchase
2.5
LEPORE PATRICK G
Non-Executive Director
25,000 +21.2%
7.32
US$183,000 		25,000 +21.2% 7.32 US$183,000
2019-02-13 2019-02-12 B Purchase
2.5
LEPORE PATRICK G
Non-Executive Director
25,000 +26.9%
8.93
US$223,250 		25,000 +26.9% 8.93 US$223,250
2019-02-11 2019-02-11 PP Planned purchase
Crew Timothy C

Chief Executive Officer

Officer
4,000 +9.5%
8.48
US$33,920 		4,000 +9.5% 8.48 US$33,920
2018-12-17 2018-12-14 B Purchase Chapman John C Non-Executive Director
10,000 +388.5%
4.93
US$49,300 		10,000 +388.5% 4.93 US$49,300
2018-12-17 2018-12-13 B Purchase LEPORE PATRICK G Non-Executive Director
25,000 +36.8%
5.10
US$127,500 		25,000 +36.8% 5.10 US$127,500
2018-12-14 2018-12-13 B Purchase PAONESSA ALBERT III Non-Executive Director
10,000 +33.0%
5.07
US$50,700 		10,000 +33.0% 5.07 US$50,700
2018-12-14 2018-12-12 B Purchase FARBER JEFFREY Non-Executive Director
10,000 +0.5%
5.32
US$53,200 		10,000 +0.5% 5.32 US$53,200
2018-11-13 2018-11-09 PP Planned purchase Crew Timothy C

Chief Executive Officer

Officer
2,000 +5.0%
5.35
US$10,700 		2,000 +5.0% 5.35 US$10,700
2018-09-04 2018-08-31 B Purchase LEPORE PATRICK G Non-Executive Director
25,000 +58.3%
5.34
US$133,500 		25,000 +58.3% 5.34 US$133,500
2018-08-30 2018-08-29 PP Planned purchase Crew Timothy C

Chief Executive Officer

Officer
2,000 +5.5%
5.51
US$11,020 		2,000 +5.5% 5.51 US$11,020
2018-06-15 2018-06-14 S Sale SMITH KEVIN

Senior VP of Sales
11,667 -38.7%
16.51
US$192,622 		11,667 -38.7% 16.51 US$192,622
2018-05-14 2018-05-11 B Purchase LEPORE PATRICK G Non-Executive Director
25,000 +1470.6%
15.13
US$378,250 		25,000 +1470.6% 15.13 US$378,250
2018-05-11 2018-05-10 PP Planned purchase Crew Timothy C

Chief Executive Officer

Officer
2,000 +11.8%
14.73
US$29,460 		2,000 +11.8% 14.73 US$29,460
2018-01-10 2018-01-09 PlS Planned sale FARBER DAVID Large shareholder
10,000 -0.2%
25.01
US$250,100 		10,000 -0.2% 25.01 US$250,100
2017-12-15 2017-12-13 S Sale FARBER DAVID Large shareholder
184 -0.0%
30.00
US$5,520 		184 -0.0% 30.00 US$5,520
2017-12-06 2017-12-05 PlS Planned sale FARBER DAVID Large shareholder
8,716 -0.2%
30.05
US$261,916 		8,716 -0.2% 30.05 US$261,916
2017-12-06 2017-12-04 PlS Planned sale FARBER DAVID Large shareholder
1,100 -0.0%
30.01
US$33,011 		1,100 -0.0% 30.01 US$33,011
2017-12-04 2017-12-01 PlS Planned sale FARBER DAVID Large shareholder
10,000 -0.2%
26.88
US$268,800 		10,000 -0.2% 26.88 US$268,800
2017-11-27 2017-11-27 S Sale BEDROSIAN ARTHUR P

CEO

Executive Director
578 -0.1%
27.45
US$15,866 		578 -0.1% 27.45 US$15,866
2017-11-27 2017-11-24 S Sale BEDROSIAN ARTHUR P

CEO

Executive Director
50,000 -7.9%
26.75
US$1,337,500 		50,000 -7.9% 26.75 US$1,337,500
2017-11-27 2017-11-22 S Sale BEDROSIAN ARTHUR P

CEO

Executive Director
42,000 -6.2%
25.50
US$1,071,000 		42,000 -6.2% 25.50 US$1,071,000
2017-11-09 2017-11-08 S Sale BEDROSIAN ARTHUR P

CEO

Executive Director
7,422 -1.1%
25.20
US$187,034 		7,422 -1.1% 25.20 US$187,034
2017-11-09 2017-11-08 PlS Planned sale FARBER DAVID Large shareholder
9,800 -0.2%
25.03
US$245,294 		9,800 -0.2% 25.03 US$245,294
2017-11-09 2017-11-07 PlS Planned sale FARBER DAVID Large shareholder
200 -0.0%
25.00
US$5,000 		200 -0.0% 25.00 US$5,000
2017-02-06 2017-02-06 B Purchase BEDROSIAN ARTHUR P

CEO

Executive Director
10,000 +1.5%
20.00
US$200,000 		10,000 +1.5% 20.00 US$200,000
2016-12-15 2016-12-13 PlS Planned sale FARBER DAVID Large shareholder
200 -0.0%
25.00
US$5,000 		200 -0.0% 25.00 US$5,000
2016-12-15 2016-12-09 PlS Planned sale FARBER DAVID Large shareholder
6,000 -0.3%
25.30
US$151,800 		6,000 -0.3% 25.30 US$151,800
2016-12-05 2016-12-02 PlS Planned sale FARBER DAVID Large shareholder
3,800 -0.2%
25.00
US$95,000 		3,800 -0.2% 25.00 US$95,000
2016-09-16 2016-09-15 S Sale Landis G. Michael

Principal Accounting Officer

Officer
4,334 -67.1%
32.30
US$139,988 		4,334 -67.1% 32.30 US$139,988
2016-09-01 2016-09-01 PlS Planned sale Maher James M. Non-Executive Director
1,478 -6.8%
33.91
US$50,119 		1,478 -6.8% 33.91 US$50,119
2016-09-01 2016-08-31 S Sale Landis G. Michael

Principal Accounting Officer

Officer
453 -17.6%
33.40
US$15,130 		453 -17.6% 33.40 US$15,130
2016-09-01 2016-08-31 S Sale Landis G. Michael

Principal Accounting Officer

Officer
4,333 -62.7%
33.41
US$144,766 		4,333 -62.7% 33.41 US$144,766
2016-09-01 2016-08-31 S Sale Landis G. Michael

Principal Accounting Officer

Officer
2,000 -43.7%
33.41
US$66,820 		2,000 -43.7% 33.41 US$66,820
2016-06-24 2016-06-23 PlS Planned sale Ehlinger Robert

VP and CIO

Officer
20,977 -52.3%
25.02
US$524,845 		20,977 -52.3% 25.02 US$524,845
2016-06-24 2016-06-22 PlS Planned sale Ehlinger Robert

VP and CIO

Officer
16,164 -28.7%
25.12
US$406,040 		16,164 -28.7% 25.12 US$406,040
2016-06-22 2016-06-20 PlS Planned sale Ehlinger Robert

VP and CIO

Officer
62,859 -52.8%
25.40
US$1,596,619 		62,859 -52.8% 25.40 US$1,596,619
2016-03-02 2016-03-01 S Sale Ehlinger Robert

VP of Logistics and CIO

Officer
69,247 -36.8%
25.41
US$1,759,566 		69,247 -36.8% 25.41 US$1,759,566
2016-07-06 2016-02-05 B Purchase Dedhiya Mahendra

Chief Scientific Affairs

Officer
1,000 +inf%
24.84
US$24,840 		1,000 +inf% 24.84 US$24,840
Explore more

More insider trading research around Lannett Company Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America